Health

Results: 2893-2904 of 9264

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

PR Newswire associated0

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

PR Newswire associated0

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

PR Newswire associated0

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025

Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025

ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe

PR Newswire associated0

Newronika Appoints Keith Carlton as Executive Chairman to Reinforce Strategic Leadership

Locate Bio Expands RESTORE Clinical Study to the United States Following FDA IDE Approval

U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease

Ronovo Surgical Closes Series D Financing

Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC

PR Newswire associated0

'CART BP pro' Opens a New Paradigm in Blood Pressure Management, Maintaining Accuracy Across Arm Positions